Renal effects of tramadol addiction and cannabinoid abuse

Research Journal of Pharmaceutical, Biological and Chemical Sciences

Volumn 6, Issue 1, 2015, Pages 1212-1218

  El Safty, I A M ^a   Mohy El Deen, I E ^b   El Rasheed, A H ^c   El Ashmawy, M F M ^d  

^a Ain Shams University   (Egypt)

^b Port Said University   (Egypt)

^c AIN SHAMS UNIVERSITY   (Egypt)

^d PORT SAID UNIVERSITY   (Egypt)

Author keywords

Alpha 1 microglobulin; Cannabinoid; Leucine aminopeptidase; Microalbumin; N acetyl beta D glucosaminidase; Tramadol

Indexed keywords

ALBUMIN; ALPHA 1 MICROGLOBULIN; CANNABINOID; CREATININE; CYTOSOL AMINOPEPTIDASE; N ACETYL BETA GLUCOSAMINIDASE; TRAMADOL;

ADOLESCENT; ADULT; AGE; ARTICLE; CANNABIS ADDICTION; CLINICAL ARTICLE; CONTROLLED STUDY; EGYPT; GLOMERULAR DYSFUNCTION; HUMAN; KIDNEY FUNCTION; MALE; MICROALBUMINURIA; MULTIPLE DRUG ABUSE; NARCOTIC DEPENDENCE; PROTEIN URINE LEVEL; TUBULAR DYSFUNCTION;

EID: 84921495331     PISSN: None     EISSN: 09758585     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. El-Akabawi AS. World Psychiatric Association Series 2001, pp. 143-150.
2. Paar WD, Frankus P, Dengler HJ. Clin Investig 1992;70(8):708-10.
3. Schenck EG, Arend I. Arzneimittelforschung 1978;28(1a):209-12.
4. Grond S, Sablotzki A. Clin Pharmacokinet 2004;43(13):879-923.
5. Boumendjel A, Sotoing Taïwe G, Ngo Bum E, Chabrol T, Beney C, Sinniger V, et al. Angew Chem Int Ed Engl 2013;52(45):11780-4.
6. Kusari S, Tatsimo SJ, Zühlke S, Talontsi FM, Kouam SF, Spiteller M. Angew Chem Int Ed Engl 2014;53(45):12073-6.
7. Miranda HF, Pinardi G. Pharmacol Biochem Behav 1998;61(4):357-60.
8. Kitahara M, Kojima K, Hanada M, Kuriyama Y, Ohmura A. Masui 2009;58(8):971-5.
9. Tjäderborn M, Jönsson AK, Ahlner J, Hägg S. Pharmacoepidemiol Drug Saf 2009;18(12):1192-8.
10. Lanier RK, Lofwall MR, Mintzer MZ, Bigelow GE, Strain EC. Psychopharmacology (Berl) 2010;211(4):457-66.
11. Knisely JS, Campbell ED, Dawson KS, Schnoll SH. Drug Alcohol Depend 2002;68(1):15-22.
12. Cicero TJ, Adams EH, Geller A, Inciardi JA, Muñoz A, Schnoll SH, et al. Drug Alcohol Depend 1999;57(1):7-22.
13. Zhang H, Liu Z. Biomed Res Int 2013;2013:283425.
14. Wu WN, McKown LA, Liao S. Xenobiotica 2002;32(5):411-25.
15. Lintz W, Erlaçin S, Frankus E, Uragg H. Arzneimittelforschung 1981;31(11):1932-43.
16. Gutustein HB, Akil H. New York: McGraw-Hill. 2001; 10th ed. pp. 569-620.
17. Leppert W, Mikolajczak P. Curr Pharm Biotechnol 2011;12(2):306-12.
18. European Monitoring Centre for Drugs and Drug Addiction. Office for Official Publications of the European Communities, Luxembourg. 2004, p. 28-30.
19. Elsohly MA, Slade D. Life Sci 2005;78(5):539-48.
20. Mechoulam R. Science 1970;168(3936):1159-66.
21. Wollner HJ, Matchett JR, Levine J, Loewe S. J Am Chem Soc 1942;64(1):26-9.
22. Gaoni Y, Mechoulam R. J Am Chem Soc 1964;86(8):1646-7.
23. Krishna DR, Klotz U. Clin Pharmacokinet 1994; 26(2):144-60.
24. Jones AB, El Sohly HN, Arafat ES, El Sohly MA. J Anal Toxicol 1984;8(6):249-51.
25. Wall ME, Sadler BM, Brine D, Taylor H, Perez-Reyes M. Clin Pharmacol Ther. 1983;34(3):352-63.
26. Bachs L, Mørland H. Forensic Sci Int 2001;124(2-3):200-3.
27. Lambrecht GL, Malbrain ML, Coremans P, Verbist L, Verhaegen H. Nephron 1995;70(4):494-6.
28. Le Guen PY, Gestin S, Plat E, Quéhé P, Bressollette L. J Mal Vasc 2011;36(1):41-4.
29. Mueller PW, Lash LH, Price RG, Stolte H, Gelpi E, Maack T, et al. Ren Fail 1997;19(4):505-21.
30. Zuppi C, Baroni S, Scribano D, Di Salvo S, Musumeci V. Ann Clin Biochem 1995;32(Pt 4):373-8.
31. Molnar A, Lewis J, Fu S. Forensic Sci Int. 2013; 227(1-3):69-73.
32. Lemann J Jr, Doumas BT. Clin Chem 1987;33(2 Pt 1):297-9.
33. Woolerton J, Jury DR, Dunn PJ, Speed JF. N Z Med J 1987;100(819):130-4.
34. Jung K. Eur J Clin Chem Clin Biochem 1991;29(11):725-9.
35. Musso CG, Oreopoulos DG. Nephron Physiol. 2011;119 (S1):1-5.
36. Kimmel PL, Alam S, Lew SQ. Renal disease in patients with substance abuse. In: Schena FP editor. Nephrology. London: McGraw-Hill. 2001; pp. 237-43.
37. Christensen EI, Birn H, Rippe B, Maunsbach AB. Kidney Int. 2007;72(10):1192-4.
38. Thrailkill KM, Nimmo T, Bunn RC, Cockrell GE, Moreau CS, Mackintosh S, et al. Diabetes Care 2009;32(7):1266-8.
39. Atici S, Cinel I, Cinel L, Doruk N, Eskandari G, Oral U. J Biosci 2005;30(2):245-52.
40. Pertwee RG. Addict Biol. 2008;13(2):147-59.
41. Tewari SN, Sharma JD. Toxicol Lett 1980;5(3-4):279-81.
42. Bohatyrewicz M, Urasinska E, Rozanski J, Ciechanowski K. Transplant Proc 2007;39(10):3054-6.
43. Yassa HA, Dawood Ael W, Shehata MM, Abdel-Hady RH, Aal KM. Hum Exp Toxicol 2010;29(1):37-47.
44. De Decker K, Cordonnier J, Jacobs W, Coucke V, Schepens P, Jorens PG. Forensic Sci Int. 2008;175(1):79-82.
45. Sommer GL, Schmid R, Lubec G. Drug Alcohol Depend 1985;16(3):287-9.
46. st ed. 1999; p. 293-300.